Adverse drug reactions to nonsteroidal anti-inflammatory drugs, COX-2 inhibitors and paracetamol in a paediatric hospital

作者: Thirza Titchen , Noel Cranswick , Sean Beggs

DOI: 10.1111/J.1365-2125.2005.02444.X

关键词:

摘要: Aims  The use of nonsteroidal anti-inflammatory drugs (NSAIDs) in children has rapidly escalated over the last 5 years Australia. This is primarily as a result availability ibuprofen an over-the-counter preparation. Several recent, significant adverse drug reactions (ADRs) to NSAIDs, at Royal Children's Hospital (RCH) Melbourne, Australia prompted review all RCH reported these agents 5 years. Methods  ADR programme documents both spontaneously ADRs and identified by discharge coding. For this study, aspirin, celecoxib, ibuprofen, indomethacin, naproxen, paracetamol rofecoxib, for previous 5-year period, were retrieved from hospital database. Results  Nineteen reports NSAIDs six paracetamol, patients aged 4 months 22 years (median 10 years) identified. Reactions predominantly rash (n = 10), gastrointestinal (n = 5) respiratory (n = 4) side-effects. These included haematemesis with celecoxib ibuprofen. One patient died severe acute exacerbation asthma following initiation rofecoxib. Conclusion  NSAID exposures are cause morbidity children. Both nonselective newer COX-2 inhibitors associated reactions. overall severity highlights need vigilant surveillance paediatrics, including established agents.

参考文章(21)
Piero Impicciatore, Imti Choonara, Amanda Clarkson, Davide Provasi, Chiara Pandolfini, Maurizio Bonati, Incidence of adverse drug reactions in paediatric in/out-patients: a systematic review and meta-analysis of prospective studies. British Journal of Clinical Pharmacology. ,vol. 52, pp. 77- 83 ,(2001) , 10.1046/J.0306-5251.2001.01407.X
Tim Ulinski, Vincent Guigonis, Olivier Dunan, Albert Bensman, Acute renal failure after treatment with non-steroidal anti-inflammatory drugs. European Journal of Pediatrics. ,vol. 163, pp. 148- 150 ,(2004) , 10.1007/S00431-003-1392-7
Renan A. Bonnel, Maria L. Villalba, Claudia B. Karwoski, Julie Beitz, Aseptic meningitis associated with rofecoxib. JAMA Internal Medicine. ,vol. 162, pp. 713- 715 ,(2002) , 10.1001/ARCHINTE.162.6.713
A Clarkson, I Choonara, Surveillance for fatal suspected adverse drug reactions in the UK Archives of Disease in Childhood. ,vol. 87, pp. 462- 466 ,(2002) , 10.1136/ADC.87.6.462
Samuel M. Lesko, An Assessment of the Safety of Pediatric Ibuprofen JAMA. ,vol. 273, pp. 929- 933 ,(1995) , 10.1001/JAMA.1995.03520360043037
Michael Passero, Sapna Chowdhry, Cyclooxygenase-2 Inhibitors in Aspirin-Sensitive Asthma Chest. ,vol. 123, pp. 2155- 2156 ,(2003) , 10.1378/CHEST.123.6.2155
Wandana Joshi, Neil Roy Connelly, Scott S. Reuben, Marten Wolckenhaar, Nikhil Thakkar, An evaluation of the safety and efficacy of administering rofecoxib for postoperative pain management. Anesthesia & Analgesia. ,vol. 97, pp. 35- 38 ,(2003) , 10.1213/01.ANE.0000069507.93582.6E
IMTI CHOONARA, ANDREA GILL, ANTHONY NUNN, Drug toxicity and surveillance in children British Journal of Clinical Pharmacology. ,vol. 42, pp. 407- 410 ,(1996) , 10.1046/J.1365-2125.1996.04563.X
Donald D. Stevenson, Ronald A. Simon, Lack of cross-reactivity between rofecoxib and aspirin in aspirin-sensitive patients with asthma. The Journal of Allergy and Clinical Immunology. ,vol. 108, pp. 47- 51 ,(2001) , 10.1067/MAI.2001.116290
Cristina Martín-García, Miguel Hinojosa, Pilar Berges, Encarnación Camacho, Rosa García-Rodriguez, Teresa Alfaya, Alberto Iscar, Safety of a cyclooxygenase-2 inhibitor in patients with aspirin-sensitive asthma. Chest. ,vol. 121, pp. 1812- 1817 ,(2002) , 10.1378/CHEST.121.6.1812